Calcicar 500 mg is indicated for the prevention and treatment of calcium deficiency associated with:
It is also commonly used to manage hyperphosphataemia in patients with chronic kidney disease, including those receiving haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). In some cases, dietary phosphate restriction or additional phosphate binders may be required for optimal phosphate control.
Calcicar 500 mg may also provide temporary relief of dyspeptic symptoms, although prolonged use as an antacid for peptic ulcer disease is generally not recommended.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Calcicar 500 mg is a calcium carbonate preparation that serves as both a calcium supplement and an antacid, depending on the tablet strength and intended clinical use.
The 250 mg and 500 mg tablets are primarily used to prevent or treat calcium deficiency, while the 1000 mg tablet is formulated for rapid relief of symptoms caused by excess stomach acid, such as heartburn and indigestion.
Calcium carbonate reacts with stomach acid to produce calcium chloride, water, and carbon dioxide, increasing gastric pH and reducing pepsin activity. This helps relieve symptoms of acid reflux and indigestion.
Approximately 30% of orally administered calcium is absorbed, mainly in the duodenum and upper small intestine through both vitamin D-dependent active transport and passive diffusion. Absorbed calcium supports:
In patients with chronic kidney disease, calcium carbonate binds dietary phosphate within the gastrointestinal tract, forming insoluble calcium phosphate that is eliminated in the stool. This lowers phosphate absorption and helps reduce the risk of secondary hyperparathyroidism and renal bone disease.
| Indication | Recommended Dose |
|---|---|
| Antacid (Adults) | 540–2000 mg daily |
| Antacid (Children) | Approximately half the adult dose |
| Calcium supplementation | 1250–3750 mg calcium carbonate daily (equivalent to 500–1500 mg elemental calcium) |
| Pregnancy & Lactation | 1200–1500 mg elemental calcium daily |
| Chronic kidney disease (phosphate binder) | 2.5–9 g daily, individualized |
Calcicar 500 mg is safe and effective for controlling phosphate levels in children with chronic kidney disease when used under medical supervision.
Older adults, especially those with kidney impairment, may be more prone to constipation and hypercalcaemia. Regular monitoring of calcium and phosphate levels is recommended during treatment.
Excessive intake may lead to hypercalcaemia or milk-alkali syndrome.
Symptoms may include:
Treatment consists of discontinuing the medication, maintaining adequate hydration, correcting electrolyte imbalances, and providing supportive medical care. Patients with chronic kidney disease require particularly close monitoring.
During prolonged or high-dose therapy, regular monitoring of serum calcium and phosphate levels is recommended.
Excessive calcium intake, especially when combined with absorbable alkali, may rarely result in milk-alkali syndrome, characterized by hypercalcaemia, metabolic alkalosis, and kidney impairment.
Calcicar 500 mg is generally considered safe during pregnancy and breastfeeding when used at recommended doses for calcium supplementation or relief of heartburn.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.